REVOLADE (Novartis Pharmaceuticals Australia Pty Ltd)
Product name
REVOLADE
Date registered
Evaluation commenced
Decision date
Approval time
192 (255 working days)
Active ingredients
eltrombopag olamine
Registration type
EOI
Indication
adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins;